News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
333,604 Results
Type
Article (20027)
Company Profile (128)
Press Release (313449)
Multimedia
Podcasts (70)
Webinars (11)
Section
Business (105458)
Career Advice (879)
Deals (18543)
Drug Delivery (97)
Drug Development (50791)
Employer Resources (79)
FDA (7701)
Job Trends (7749)
News (186004)
Policy (17353)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (735)
Accelerated approval (3)
Adcomms (17)
Allergies (40)
Alliances (27861)
ALS (54)
Alzheimer's disease (638)
Antibody-drug conjugate (ADC) (88)
Approvals (7713)
Artificial intelligence (137)
Autoimmune disease (15)
Automation (4)
Bankruptcy (177)
Best Places to Work (5556)
BIOSECURE Act (13)
Biosimilars (95)
Biotechnology (57)
Bladder cancer (31)
Brain cancer (19)
Breast cancer (105)
Cancer (1028)
Cardiovascular disease (110)
Career advice (712)
Career pathing (20)
CAR-T (55)
Cell therapy (150)
Cervical cancer (5)
Clinical research (42665)
Collaboration (451)
Compensation (162)
Complete response letters (23)
COVID-19 (1099)
CRISPR (22)
C-suite (146)
Cystic fibrosis (57)
Data (1102)
Decentralized trials (2)
Denatured (18)
Depression (24)
Diabetes (138)
Diagnostics (1809)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (21)
Drug discovery (80)
Drug pricing (108)
Drug shortages (30)
Duchenne muscular dystrophy (59)
Earnings (39031)
Editorial (30)
Employer branding (10)
Employer resources (73)
Events (48572)
Executive appointments (428)
FDA (8272)
Featured Employer (23)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (307)
Gene editing (46)
Generative AI (18)
Gene therapy (144)
GLP-1 (584)
Government (1845)
Grass and pollen (2)
Guidances (18)
Healthcare (5911)
Huntington's disease (13)
IgA nephropathy (20)
Immunology and inflammation (81)
Indications (17)
Infectious disease (1179)
Inflammatory bowel disease (82)
Inflation Reduction Act (8)
Influenza (25)
Intellectual property (55)
Interviews (116)
IPO (7369)
IRA (45)
Job creations (2432)
Job search strategy (648)
Kidney cancer (7)
Labor market (21)
Layoffs (276)
Leadership (14)
Legal (4118)
Liver cancer (31)
Lung cancer (156)
Lymphoma (84)
Machine learning (2)
Management (30)
Manufacturing (197)
MASH (49)
Medical device (1976)
Medtech (1979)
Mergers & acquisitions (11421)
Metabolic disorders (486)
Multiple sclerosis (48)
NASH (20)
Neurodegenerative disease (49)
Neuropsychiatric disorders (20)
Neuroscience (948)
NextGen: Class of 2025 (2358)
Non-profit (908)
Northern California (1059)
Now hiring (20)
Obesity (303)
Opinion (190)
Ovarian cancer (33)
Pain (65)
Pancreatic cancer (35)
Parkinson's disease (85)
Partnered (11)
Patents (137)
Patient recruitment (45)
Peanut (16)
People (33450)
Pharmaceutical (74)
Pharmacy benefit managers (21)
Phase I (13358)
Phase II (18046)
Phase III (14502)
Pipeline (701)
Policy (113)
Postmarket research (1618)
Preclinical (4656)
Press Release (29)
Prostate cancer (59)
Psychedelics (16)
Radiopharmaceuticals (161)
Rare diseases (239)
Real estate (3180)
Recruiting (29)
Regulatory (12527)
Reports (22)
Research institute (819)
Resumes & cover letters (138)
Rett syndrome (1)
RNA editing (2)
RSV (24)
Schizophrenia (59)
Series A (57)
Series B (31)
Service/supplier (7)
Sickle cell disease (35)
Southern California (1014)
Special edition (15)
Spinal muscular atrophy (111)
Sponsored (12)
Startups (2009)
State (2)
Stomach cancer (9)
Supply chain (51)
Tariffs (21)
The Weekly (50)
United States (9941)
Vaccines (268)
Venture capitalists (27)
Weight loss (236)
Women's health (14)
Worklife (7)
Date
Today (35)
Last 7 days (240)
Last 30 days (1278)
Last 365 days (16817)
2025 (4580)
2024 (17694)
2023 (19664)
2022 (25903)
2021 (26691)
2020 (24895)
2019 (20073)
2018 (15601)
2017 (17267)
2016 (16209)
2015 (18810)
2014 (14790)
2013 (12557)
2012 (13491)
2011 (13819)
2010 (12742)
Location
Africa (409)
Alabama (23)
Alaska (1)
Arizona (64)
Arkansas (8)
Asia (24902)
Australia (3223)
California (2472)
Canada (1084)
China (317)
Colorado (95)
Connecticut (98)
Delaware (69)
Europe (51421)
Florida (431)
Georgia (53)
Idaho (16)
Illinois (243)
India (19)
Indiana (171)
Iowa (3)
Japan (116)
Kansas (62)
Kentucky (17)
Louisiana (2)
Maine (4)
Maryland (360)
Massachusetts (2090)
Michigan (49)
Minnesota (135)
Mississippi (1)
Missouri (27)
Montana (10)
Nebraska (11)
Nevada (15)
New Hampshire (8)
New Jersey (1010)
New Mexico (21)
New York (722)
North Carolina (491)
North Dakota (2)
Northern California (1059)
Ohio (82)
Oklahoma (5)
Oregon (21)
Pennsylvania (587)
Puerto Rico (11)
Rhode Island (16)
South America (607)
South Carolina (3)
Southern California (1014)
Tennessee (38)
Texas (325)
Utah (54)
Virginia (82)
Washington D.C. (43)
Washington State (214)
Wisconsin (20)
333,604 Results for "asahi kasei pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Asahi Kasei Establishes Asahi Kasei Life Science to Drive its Bioprocess Businesses Forward
April 9, 2025
·
3 min read
Press Releases
Chris Rombach appointed President of Asahi Kasei Bioprocess America
February 19, 2025
·
4 min read
Press Releases
Asahi Kasei Pharma Strengthens Global Reach with Exclusive License Agreement for anti-CX3CR1 Antibody
December 11, 2024
·
3 min read
Deals
Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company
Asahi Kasei Corp. announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei through a voluntary tender offer for Calliditas.
May 28, 2024
·
7 min read
Pharm Country
Asahi Kasei Launches Membrane System to Produce Water for Injection
Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI, a type of sterile water that is used for the preparation of injections.
June 13, 2024
·
3 min read
Business
Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.
April 11, 2024
·
5 min read
Business
Asahi Kasei starts operation of multi-module hydrogen pilot plant in Kawasaki
The Japanese technology company Asahi Kasei is further accelerating its hydrogen business activities.
May 14, 2024
·
5 min read
Business
Asahi Kasei Medical and AW Technologies enter exclusive distribution agreement for TrachFlush in Japan
AW Technologies and Asahi Kasei Medical, a core operating company of the Asahi Kasei Group, have entered into an exclusive distribution agreement in Japan for AW Technologies’ TrachFlush™ device.
April 3, 2024
·
3 min read
Deals
Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation
The Board of Directors of Calliditas Therapeutics AB unanimously recommends that the shareholders and holders of American Depositary Shares of Calliditas Therapeutics AB accept the public tender offer by Asahi Kasei Corporation.
May 28, 2024
·
24 min read
Pharm Country
Crystal IS and Asahi Kasei have achieved 99% usable area on 100 mm bulk aluminum nitride substrate
Crystal IS, an Asahi Kasei company, announced the successful serial production of 100 mm diameter single-crystal aluminum nitride substrates with 99% usable area, based on current requirements for UVC LEDs, with manufacturing to take place in the United States.
June 12, 2024
·
3 min read
1 of 33,361
Next
